[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tenax Therapeutics (TENX)

Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 380,103
  • Shares Outstanding, K 26,525
  • Annual Sales, $ 0 K
  • Annual Income, $ -52,600 K
  • EBIT $ -69 M
  • EBITDA $ -69 M
  • 60-Month Beta 0.93
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.90

Options Overview Details

View History
  • Implied Volatility 519.68% (+33.73%)
  • Historical Volatility 95.54%
  • IV Percentile 99%
  • IV Rank 100.00%
  • IV High 519.68% on 08/04/26
  • IV Low 74.89% on 05/15/26
  • Expected Move (DTE 16) 11.05 (79.96%)
  • Put/Call Vol Ratio 4.91
  • Today's Volume 12,706
  • Volume Avg (30-Day) 3,105
  • Put/Call OI Ratio 0.44
  • Today's Open Interest 72,405
  • Open Int (30-Day) 50,605
  • Expected Range 2.77 to 24.87

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.39
  • Number of Estimates 4
  • High Estimate $-0.36
  • Low Estimate $-0.47
  • Prior Year $-0.40
  • Growth Rate Est. (year over year) +2.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.12 +5.34%
on 08/03/26
19.40 -28.76%
on 07/09/26
-1.64 (-10.61%)
since 07/02/26
3-Month
10.25 +34.83%
on 06/09/26
19.40 -28.76%
on 07/09/26
+0.50 (+3.75%)
since 05/04/26
52-Week
5.78 +139.10%
on 08/11/25
19.40 -28.76%
on 07/09/26
+7.64 (+123.62%)
since 08/04/25

Most Recent Stories

More News
Tenax Therapeutics: Q2 Earnings Snapshot

Tenax Therapeutics: Q2 Earnings Snapshot

TENX : 13.82 (-3.56%)
Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Company expects to report topline data from Phase 3 LEVEL clinical trial in August 2026 CHAPEL HILL, N.C., July 31, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or...

TENX : 13.82 (-3.56%)
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CHAPEL HILL, N.C., July 02, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or “Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical...

TENX : 13.82 (-3.56%)
Tenax Therapeutics Announces Late-Breaking Presentation of LEVEL Clinical Trial Data at ESC Congress 2026

Abstract recently submitted in anticipation of initial data analysis ahead of ESC Company expects to report topline LEVEL results in August CHAPEL HILL, N.C., July 02, 2026 (GLOBE NEWSWIRE)...

TENX : 13.82 (-3.56%)
Tenax Therapeutics: Q1 Earnings Snapshot

Tenax Therapeutics: Q1 Earnings Snapshot

TENX : 13.82 (-3.56%)
Tenax Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

On track to report topline data from Phase 3 LEVEL study of TNX-103 in third quarter of 2026 Global Phase 3 LEVEL-2 clinical trial ongoing, enrollment completion anticipated by end of 2027 Strengthened...

TENX : 13.82 (-3.56%)
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CHAPEL HILL, N.C., May 08, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or “Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical...

TENX : 13.82 (-3.56%)
Tenax Therapeutics Appoints Timothy Healey, MBA as Chief Commercial Officer

CHAPEL HILL, N.C., May 04, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or “Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical...

TENX : 13.82 (-3.56%)
Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer

Mr. Staab has over 25 years of financial and executive experience across the healthcare industry CHAPEL HILL, N.C., April 22, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax”...

TENX : 13.82 (-3.56%)
Tenax Therapeutics: Q4 Earnings Snapshot

Tenax Therapeutics: Q4 Earnings Snapshot

TENX : 13.82 (-3.56%)

Business Summary

Tenax Therapeutics, Inc. is a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market. The Company specializes in creating pharmaceuticals and medical devices in the fields of oxygen therapeutics, blood substitutes, and liquid ventilation...

See More

Key Turning Points

3rd Resistance Point 16.04
2nd Resistance Point 15.34
1st Resistance Point 14.58
Last Price 13.82
1st Support Level 13.12
2nd Support Level 12.42
3rd Support Level 11.66

See More

52-Week High 19.40
Fibonacci 61.8% 14.20
Last Price 13.82
Fibonacci 50% 12.59
Fibonacci 38.2% 10.98
52-Week Low 5.78

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.